ALT Excerpt from “Making Invisible Illnesses Visible: Recognizing and Responding to Infection Associated Chronic Conditions” [IACC], where Dr. Stephanie Haridopolos is listed as co-author: Five randomized clinical trials have failed to find benefit from prolonged antibiotic treatment (typically intravenous ceftriaxone, often in combination with oral doxycycline) in Lyme disease IACCI and four of the five found harms including frequent antibiotic-related adverse events, catheter and infusion complications, and occasional serious events requiring hospitalization including sepsis.7 [7 = NASEM committee report paid for by chronic Lyme pseudoscience advocates] Prolonged therapy with antibiotics also increases individual and population level risks for C. difficile infection and antimicrobial resistance, respectively. Given absence of benefit and substantial evidence of harm, there is a need to search for causes besides persistent infection which could lead to effective targeted therapies.

ALT Screenshot of an article headline in the Boston globe that reads “Long Covid may be more widespread than previously thought, Mass General Brigham study says”